EichorEICHOR
Location: Baton Rouge Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Baton Rouge

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10030 Baton Rouge, LA Investigational Site · Colorado Prevention Center · NCT06024746MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT05564390Pounce™ Thrombectomy System Retrospective Registry
Phase N/A · Baton Rouge General Medical Center · SurModics, Inc. · NCT05868161Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Mary Bird Perkins Cancer Center · Eli Lilly and Company · NCT06890598A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · LSU Health Baton Rouge North Clinic ( Site 4040) · Merck Sharp & Dohme LLC · NCT06077760A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Renal Associates of Baton Rouge · Boehringer Ingelheim · NCT07220083Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · LSU Health Baton Rouge-North Clinic · NRG Oncology · NCT05174169A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-10030, Baton Rouge, LA · Colorado Prevention Center · NCT06033950Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · LSU Health Baton Rouge-North Clinic · Alliance for Clinical Trials in Oncology · NCT04242095An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · GI Alliance - Baton Rouge - Site Number: 8400129 · Sanofi · NCT07184931Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT05256225Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT05554393Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · LSU Health Baton Rouge-North Clinic · ECOG-ACRIN Cancer Research Group · NCT04566328Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Phase N/A · Louisiana Hematology Oncology Associates LLC · Wake Forest University Health Sciences · NCT03998202Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · LSU Health Baton Rouge-North Clinic · ECOG-ACRIN Cancer Research Group · NCT04239573Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Phase 1 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT04609046Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT06317649Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · LSU Health Baton Rouge-North Clinic · ECOG-ACRIN Cancer Research Group · NCT04423211Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Mary Bird Perkins Cancer Center - Baton Rouge · OSE Immunotherapeutics · NCT06472245S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · LSU Health Baton Rouge-North Clinic · SWOG Cancer Research Network · NCT03418961A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti
Phase 3 · LSU Health Baton Rouge North Clinic ( Site 4003) · Merck Sharp & Dohme LLC · NCT06312137Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT07195734Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT06337318Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · LSU Health Baton Rouge-North Clinic · National Cancer Institute (NCI) · NCT04267848A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti
Phase 3 · GI Alliance - Baton Rouge - Site Number: 8400129 · Sanofi · NCT07185009Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · LSU Health Baton Rouge-North Clinic · ECOG-ACRIN Cancer Research Group · NCT03937635Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · LSU Health Baton Rouge - North Clinic · BioNTech SE · NCT06712355Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · LSU Health Baton Rouge-North Clinic · SWOG Cancer Research Network · NCT03851445A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · Velocity Clinical Research at The Dermatology Clinic - Baton · AbbVie · NCT06389136Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · LSU Health Baton Rouge-North Clinic · NRG Oncology · NCT06580314
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.